STAGE IIIA HEPATOCELLULAR CARCINOMA AJCC V8
Clinical trials for STAGE IIIA HEPATOCELLULAR CARCINOMA AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIA HEPATOCELLULAR CARCINOMA AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IIIA HEPATOCELLULAR CARCINOMA AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail shows promise for tough liver cancers
Disease control OngoingThis early-phase trial tests whether combining regorafenib (a targeted therapy) with durvalumab (an immunotherapy) can shrink tumors in 4 adults with high-risk liver cancer before surgery. The goal is to see if the treatment reduces tumor size enough to improve surgical outcomes.…
Matched conditions: STAGE IIIA HEPATOCELLULAR CARCINOMA AJCC V8
Phase: PHASE2 • Sponsor: Academic and Community Cancer Research United • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC
-
New combo therapy targets Hard-to-Treat liver cancer
Disease control OngoingThis early-phase study tests whether giving two immunotherapy drugs (durvalumab and tremelimumab) after a type of internal radiation (radioembolization) can help control advanced liver cancer that cannot be removed by surgery. About 25 adults with locally advanced liver cancer wi…
Matched conditions: STAGE IIIA HEPATOCELLULAR CARCINOMA AJCC V8
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Apr 30, 2026 15:50 UTC